Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tb-PSMA-I&T before radical prostatectomy in locally advanced prostate cancer
NCT07208240Phase 2Recruiting
- Sponsor
- Rabin Medical Center
- Start
- Aug 2025
- Primary completion
- Aug 2028
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of [161Tb]Tb-PSMA-I&T in prostate cancer (PCa), sponsored by Rabin Medical Center. Started Aug 2025; status: recruiting.
02
Drugs
[161Tb]Tb-PSMA-I&T
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT07208240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07208240.